Podcast: Gottlieb Addresses LDT Legislation At Brookings

US FDA Commissioner Scott Gottlieb spoke with Medtech Insight about the agency’s decision to put the LDT issue to Congress instead of using guidance-making.

Gottlieb at Brookings
FDA chief Scott Gottlieb at the Brookings Institution on March 20 • Source: Ferdous Al-Faruque

More from Regulation

More from Policy & Regulation